These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18793851)

  • 1. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators.
    Niswender CM; Lebois EP; Luo Q; Kim K; Muchalski H; Yin H; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5626-30. PubMed ID: 18793851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-lead.
    Williams R; Niswender CM; Luo Q; Le U; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2009 Feb; 19(3):962-6. PubMed ID: 19097893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold.
    Sharma S; Rodriguez AL; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4098-101. PubMed ID: 18550372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.
    Niswender CM; Johnson KA; Weaver CD; Jones CK; Xiang Z; Luo Q; Rodriguez AL; Marlo JE; de Paulis T; Thompson AD; Days EL; Nalywajko T; Austin CA; Williams MB; Ayala JE; Williams R; Lindsley CW; Conn PJ
    Mol Pharmacol; 2008 Nov; 74(5):1345-58. PubMed ID: 18664603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4).
    Williams R; Johnson KA; Gentry PR; Niswender CM; Weaver CD; Conn PJ; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4967-70. PubMed ID: 19640716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo.
    Lindsley CW; Wisnoski DD; Leister WH; O'brien JA; Lemaire W; Williams DL; Burno M; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Duggan ME; Hartman GD; Conn PJ; Huff JR
    J Med Chem; 2004 Nov; 47(24):5825-8. PubMed ID: 15537338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators.
    Zhang L; Rogers BN; Duplantier AJ; McHardy SF; Efremov I; Berke H; Qian W; Zhang AQ; Maklad N; Candler J; Doran AC; Lazzaro JT; Ganong AH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5493-6. PubMed ID: 18812259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorinated 9H-xanthene-9-carboxylic acid oxazol-2-yl-amides as potent, orally available mGlu1 receptor enhancers.
    Vieira E; Huwyler J; Jolidon S; Knoflach F; Mutel V; Wichmann J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1666-9. PubMed ID: 19233648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric Molecular Switches in Metabotropic Glutamate Receptors.
    Orgován Z; Ferenczy GG; Keserű GM
    ChemMedChem; 2021 Jan; 16(1):81-93. PubMed ID: 32686363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in the development of allosteric modulators of mGluR5.
    Rodriguez AL; Williams R
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):715-22. PubMed ID: 17987523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu
    Childress ES; Wieting JM; Felts AS; Breiner MM; Long MF; Luscombe VB; Rodriguez AL; Cho HP; Blobaum AL; Niswender CM; Emmitte KA; Conn PJ; Lindsley CW
    J Med Chem; 2019 Jan; 62(1):378-384. PubMed ID: 30350962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization.
    Duplantier AJ; Efremov I; Candler J; Doran AC; Ganong AH; Haas JA; Hanks AN; Kraus KG; Lazzaro JT; Lu J; Maklad N; McCarthy SA; O'Sullivan TJ; Rogers BN; Siuciak JA; Spracklin DK; Zhang L
    Bioorg Med Chem Lett; 2009 May; 19(9):2524-9. PubMed ID: 19328692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of molecular switches that modulate modes of metabotropic glutamate receptor subtype 5 (mGlu5) pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidines.
    Sharma S; Kedrowski J; Rook JM; Smith RL; Jones CK; Rodriguez AL; Conn PJ; Lindsley CW
    J Med Chem; 2009 Jul; 52(14):4103-6. PubMed ID: 19537763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents.
    Felts AS; Rodriguez AL; Morrison RD; Venable DF; Blobaum AL; Byers FW; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Emmitte KA
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1894-900. PubMed ID: 26988308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative mGluR4 positive allosteric modulators activate G
    Abulwerdi G; Stoica BA; Loane DJ; Faden AI
    Neurochem Int; 2020 Sep; 138():104770. PubMed ID: 32454165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5).
    Williams DL; Lindsley CW
    Curr Top Med Chem; 2005; 5(9):825-46. PubMed ID: 16178729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor.
    Pérez-Benito L; Doornbos MLJ; Cordomí A; Peeters L; Lavreysen H; Pardo L; Tresadern G
    Structure; 2017 Jul; 25(7):1153-1162.e4. PubMed ID: 28648611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.
    Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH
    Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction.
    East SP; Bamford S; Dietz MG; Eickmeier C; Flegg A; Ferger B; Gemkow MJ; Heilker R; Hengerer B; Kotey A; Loke P; Schänzle G; Schubert HD; Scott J; Whittaker M; Williams M; Zawadzki P; Gerlach K
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4901-5. PubMed ID: 20638279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mGluR4 positive allosteric modulators with potential for the treatment of Parkinson's disease: WO09010455.
    East SP; Gerlach K
    Expert Opin Ther Pat; 2010 Mar; 20(3):441-5. PubMed ID: 20180624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.